$2.43
+0.10 (+4.29%)
Open$2.33
Previous Close$2.33
Day High$2.46
Day Low$2.33
52W High$12.37
52W Low$1.81
Volume—
Avg Volume132.4K
Market Cap19.82M
P/E Ratio—
EPS$-1.77
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+698.8% upside
Current
$2.43
$2.43
Target
$19.41
$19.41
$13.09
$19.41 avg
$19.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.96M | 1.87M | 22.16M |
| Net Income | -14,412,985 | -8,203,697 | 3.56M |
| Profit Margin | -487.1% | -462.7% | 16.1% |
| EBITDA | -15,435,084 | -9,273,545 | 4.85M |
| Free Cash Flow | — | — | 3.49M |
| Rev Growth | +58.1% | +58.1% | +9.7% |
| Debt/Equity | — | — | 0.13 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |